COFFEE BEVERAGE AND PROCESS FOR PRODUCING SAME
    3.
    发明申请
    COFFEE BEVERAGE AND PROCESS FOR PRODUCING SAME 审中-公开
    咖啡饮料及其生产方法

    公开(公告)号:US20140087054A1

    公开(公告)日:2014-03-27

    申请号:US14006126

    申请日:2012-03-23

    申请人: MEIJI CO., LTD.

    IPC分类号: A23F5/24

    摘要: Provided is a coffee beverage which achieves a good balance between sweet, bitter, and unpleasant tastes at both liquid temperatures of 10° C. or less, which is a liquid-temperature of the beverage while refrigerated, and around ordinary temperature (for example, 20 to 30° C.), which is an assumed liquid temperature of the beverage when it is drunk. The coffee beverage comprises fructose, maltose, and a cacao extract. Fructose is contained in a form of, for example, glucose-fructose syrup. Maltose is contained in a form of, for example, maltose syrup. The content of glucose-fructose syrup and the content of maltose syrup in the coffee beverage are each preferably 1 to 10% by weight. The weight ratio between glucose-fructose syrup and maltose syrup is preferably 3:1 to 1:3. The content of the cacao extract in the coffee beverage is preferably 0.01 to 0.1% by weight. The coffee beverage can further comprise sugar.

    摘要翻译: 本发明提供一种咖啡饮料,其在10℃以下的液体温度下,即在饮料的液体温度以及常温下(例如,温度等)下,在甜味,苦味和不愉快的口味之间达到良好的平衡, 20至30℃),这是饮料在饮用时的假设液体温度。 咖啡饮料包括果糖,麦芽糖和可可提取物。 果糖以例如葡萄糖 - 果糖糖浆的形式包含。 麦芽糖以麦芽糖糖浆的形式包含。 葡萄糖 - 果糖糖浆的含量和咖啡饮料中的麦芽糖糖浆的含量各自优选为1〜10重量%。 葡萄糖 - 果糖浆与麦芽糖浆之间的重量比优选为3:1至1:3。 咖啡饮料中的可可提取物的含量优选为0.01〜0.1重量%。 咖啡饮料还可以包含糖。

    Rubrofusarin glycoside-containing composition
    4.
    发明申请
    Rubrofusarin glycoside-containing composition 审中-公开
    含Rubrofusarin糖苷的组合物

    公开(公告)号:US20080182803A1

    公开(公告)日:2008-07-31

    申请号:US11984931

    申请日:2007-11-26

    申请人: Sumio Asami

    发明人: Sumio Asami

    IPC分类号: A61K31/7048 A61P1/16

    摘要: There is provided an oral composition capable of stimulating intracellular biosynthesis of glutathione in order to maintain in-vivo (i.e., in tissues and cells) glutathione level at a high level, by adding an active ingredient other than an amino acid precursor from a viewpoint of increasing intracellular glutathione synthesis, as a method which is an alternative or can be combined with a method of supplying an amino acid precursor to be used in glutathione biosynthesis. The oral composition is used for maintaining or increasing intracellular glutathione level and contains at least one rubrofusarin glycoside in an amount that is effective for increasing the intracellular glutathione.

    摘要翻译: 提供了能够刺激谷胱甘肽的细胞内生物合成的口服组合物,以通过添加除氨基酸前体以外的活性成分从而维持在高水平的体内(即组织和细胞)谷胱甘肽水平,从 增加细胞内谷胱甘肽合成,作为替代方法或可以与供应用于谷胱甘肽生物合成的氨基酸前体的方法组合的方法。 口服组合物用于维持或增加细胞内谷胱甘肽水平,并且含有至少一种对增加细胞内谷胱甘肽有效的量的鲁鲁夫菌素苷。

    Rubrofusarin glycoside-containing composition
    5.
    发明申请
    Rubrofusarin glycoside-containing composition 审中-公开
    含Rubrofusarin糖苷的组合物

    公开(公告)号:US20060110474A1

    公开(公告)日:2006-05-25

    申请号:US10516288

    申请日:2003-05-30

    申请人: Sumio Asami

    发明人: Sumio Asami

    IPC分类号: A61K36/482 A61K31/7048

    摘要: There is provided an oral composition capable of strimulating intracellular biosynthesis of glutathione in order to maintain in-vivo (i.e., in tissues and cells) glutathione level at a high level, by adding an active ingredient other than an amino acid precursor from a viewpoint of increasing intracellular glutathione synthesis, as a method which is an alternative or can be combined with a method of supplying an amino acid precursor to be used in glutathione biosynthesis. The oral composition is used for maintaining or increasing intracellular glutathione level and contains at least one rubrofusarin glycoside in an amount that is effective for increasing the intracellular glutathione.

    摘要翻译: 提供一种口服组合物,其能够刺激谷胱甘肽的细胞内生物合成,以通过从氨基酸前体的添加中添加除氨基酸前体以外的活性成分,从而维持体内(即组织和细胞)谷胱甘肽水平的高水平 增加细胞内谷胱甘肽合成,作为替代方法或可以与供应用于谷胱甘肽生物合成的氨基酸前体的方法组合的方法。 口服组合物用于维持或增加细胞内谷胱甘肽水平,并且含有至少一种对增加细胞内谷胱甘肽有效的量的鲁鲁夫菌素苷。